RAPP Earnings & Financial Statements
Rapport Therapeutics, Inc. Common Stock
$28.33
-$0.66(-2.28%)
31
Overall
55
Value
9
Tech
31
Quality
Market Cap
$1.36B
Volume
304.00K
52W Range
$23.75 - $52.93
Target Price
$61.92
RAPP earnings and financial statements: Rapport Therapeutics, Inc. Common Stock's income statement, balance sheet and cash flow statement, annual and quarterly.
RAPP Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | -$125.10M | -$83.06M | -$36.18M |
| EBITDA | -$108.43M | -$76.83M | -$34.66M |
| Net income | -$111.48M | -$78.31M | -$34.79M |
| EPS (diluted) | $-2.86 | $-3.78 | $-23.10 |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total assets | $512.43M | $314.93M | $155.42M |
| Total liabilities | $27.78M | $9.51M | $14.48M |
| Shareholders’ equity | $484.65M | $305.43M | $140.94M |
| Cash and equivalents | $52.65M | $56.80M | $70.17M |
| Long-term debt | $8.73M | $739.0K | - |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating cash flow | -$87.47M | -$64.83M | -$27.18M |
| Capital expenditure | -$616.0K | -$2.40M | - |
| Free cash flow | -$88.09M | -$67.23M | -$28.81M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RAPP | $28.33 | -2.3% | 304.00K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rapport Therapeutics, Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW